Literature DB >> 16199696

New and lingering controversies in pediatric end-of-life care.

Mildred Z Solomon1, Deborah E Sellers, Karen S Heller, Deborah L Dokken, Marcia Levetown, Cynda Rushton, Robert D Truog, Alan R Fleischman.   

Abstract

OBJECTIVES: Professional societies, ethics institutes, and the courts have recommended principles to guide the care of children with life-threatening conditions; however, little is known about the degree to which pediatric care providers are aware of or in agreement with these guidelines. The study's objectives were to determine the extent to which physicians and nurses in critical care, hematology/oncology, and other subspecialties are in agreement with one another and with widely published ethical recommendations regarding the withholding and withdrawing of life support, the provision of adequate analgesia, and the role of parents in end-of-life decision-making.
METHODS: Three children's hospitals and 4 general hospitals with PICUs in eastern, southwestern, and southern parts of the United States were surveyed. This population-based sample was composed of attending physicians, house officers, and nurses who cared for children (age: 1 month to 18 years) with life-threatening conditions in PICUs or in medical, surgical, or hematology/oncology units, floors, or departments. Main outcome measures included concerns of conscience, knowledge and beliefs, awareness of published guidelines, and agreement or disagreement with guidelines.
RESULTS: A total of 781 clinicians were sampled, including 209 attending physicians, 116 house officers, and 456 nurses. The overall response rate was 64%. Fifty-four percent of house officers and substantial proportions of attending physicians and nurses reported, "At times, I have acted against my conscience in providing treatment to children in my care." For example, 38% of critical care attending physicians and 25% of hematology/oncology attending physicians expressed these concerns, whereas 48% of critical care nurses and 38% of hematology/oncology nurses did so. Across specialties, approximately 20 times as many nurses, 15 times as many house officers, and 10 times as many attending physicians agreed with the statement, "Sometimes I feel we are saving children who should not be saved," as agreed with the statement, "Sometimes I feel we give up on children too soon." However, hematology/oncology attending physicians (31%) were less likely than critical care (56%) and other subspecialty (66%) attending physicians to report, "Sometimes I feel the treatments I offer children are overly burdensome." Many respondents held views that diverged widely from published recommendations. Despite a lack of awareness of key guidelines, across subspecialties the vast majority of attending physicians (range: 92-98%, depending on specialty) and nurses (range: 83-85%) rated themselves as somewhat to very knowledgeable regarding ethical issues.
CONCLUSIONS: There is a need for more hospital-based ethics education and more interdisciplinary and cross-subspecialty discussion of inherently complex and stressful pediatric end-of-life cases. Education should focus on establishing appropriate goals of care, as well as on pain management, medically supplied nutrition and hydration, and the appropriate use of paralytic agents. More research is needed on clinicians' regard for the dead-donor rule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199696     DOI: 10.1542/peds.2004-0905

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  An exploratory survey of end-of-life attitudes, beliefs, and experiences of adolescents with HIV/AIDS and their families.

Authors:  Patricia A Garvie; Jianping He; Jichuan Wang; Lawrence J D'Angelo; Maureen E Lyon
Journal:  J Pain Symptom Manage       Date:  2012-07-07       Impact factor: 3.612

2.  The iCritical care podcast: a novel medium for critical care communication and education.

Authors:  Richard H Savel; Evan B Goldstein; Eli N Perencevich; Peter B Angood
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

3.  Pediatric End-of-Life Issues and Palliative Care.

Authors:  Kelly Nicole Michelson; David M Steinhorn
Journal:  Clin Pediatr Emerg Med       Date:  2007-09

4.  Moral distress, moral residue, and the crescendo effect.

Authors:  Elizabeth Gingell Epstein; Ann Baile Hamric
Journal:  J Clin Ethics       Date:  2009

5.  FAmily CEntered (FACE) advance care planning: Study design and methods for a patient-centered communication and decision-making intervention for patients with HIV/AIDS and their surrogate decision-makers.

Authors:  Allison L Kimmel; Jichuan Wang; Rachel K Scott; Linda Briggs; Maureen E Lyon
Journal:  Contemp Clin Trials       Date:  2015-06-02       Impact factor: 2.226

Review 6.  Pediatric palliative care in the intensive care unit and questions of quality: a review of the determinants and mechanisms of high-quality palliative care in the pediatric intensive care unit (PICU).

Authors:  Sara Rhodes Short; Rachel Thienprayoon
Journal:  Transl Pediatr       Date:  2018-10

7.  Ethics consultation in pediatrics: long-term experience from a pediatric oncology center.

Authors:  Liza-Marie Johnson; Christopher L Church; Monika Metzger; Justin N Baker
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

8.  Perinatal and pediatric issues in palliative and end-of-life care from the 2011 Summit on the Science of Compassion.

Authors:  Jonne M Youngblut; Dorothy Brooten
Journal:  Nurs Outlook       Date:  2012-10-01       Impact factor: 3.250

9.  Management dilemmas in pediatric nephrology: time-limited trials of dialysis therapy.

Authors:  Aaron Wightman
Journal:  Pediatr Nephrol       Date:  2016-12-09       Impact factor: 3.714

10.  Cause of Death of Infants and Children in the Intensive Care Unit: Parents' Recall vs Chart Review.

Authors:  Dorothy Brooten; JoAnne M Youngblut; Carmen Caicedo; Lynn Seagrave; G Patricia Cantwell; Balagangadhar Totapally
Journal:  Am J Crit Care       Date:  2016-05       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.